Neogenomics (NEO) Operating Income (2010 - 2026)
Neogenomics (NEO) reported Operating Income of -$18.2 million for Q1 2026, up 34.44% on a YoY basis from -$13.6 million in Q1 2025, and down 35.98% quarter-over-quarter from -$13.4 million in Q4 2025.
Neogenomics (NEO) Operating Income (2010 - 2026) Analysis & Trends
Neogenomics has reported Operating Income for 17 years, with the latest figure at -$18.2 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 34.44% year-over-year to -$18.2 million; the trailing twelve-month figure through Mar 2026 stood at -$106.3 million (down 18.95% YoY), and the FY2025 full-year result was -$115.9 million, down 25.81% from the prior year.
- Operating Income for Q1 2026 stood at -$18.2 million, down from -$13.4 million in the prior quarter.
- The five-year high for Operating Income was -$13.4 million in Q4 2025, with the low at -$52.0 million in Q1 2022.
- Historically, Operating Income has averaged -$28.9 million across 5 years, with a median of -$27.0 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Income slumped 244.4% — and 2023, when it soared 38.76%.
- Neogenomics' Operating Income stood at -$26.4 million in 2022, then grew by 29.6% to -$18.6 million in 2023, then grew by 0.93% to -$18.4 million in 2024, then grew by 27.1% to -$13.4 million in 2025, then tumbled by 35.98% to -$18.2 million in 2026.
- The last three Operating Income figures came in at -$18.2 million (Q1 2026), -$13.4 million (Q4 2025), and -$27.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -47.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.86 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.34 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 362.59 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 399.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -93.52 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 514.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 209.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 238.95 Mn |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | -18.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.24 Mn |
| Dec 31, 2025 | -13.41 Mn |
| Sep 30, 2025 | -27.01 Mn |
| Jun 30, 2025 | -47.63 Mn |
| Mar 31, 2025 | -27.83 Mn |
| Dec 31, 2024 | -18.40 Mn |
| Sep 30, 2024 | -21.20 Mn |
| Jun 30, 2024 | -21.94 Mn |
| Mar 31, 2024 | -30.57 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -24.20 Mn |
| Jun 30, 2023 | -29.89 Mn |
| Mar 31, 2023 | -35.07 Mn |
| Dec 31, 2022 | -26.38 Mn |
| Sep 30, 2022 | -39.51 Mn |
| Jun 30, 2022 | -39.70 Mn |
| Mar 31, 2022 | -52.03 Mn |
| Dec 31, 2021 | -41.57 Mn |
| Sep 30, 2021 | -39.71 Mn |
| Jun 30, 2021 | -22.37 Mn |